Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Better Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20
Revenues0.00.0
            Revenue growth-100.0% 
Cost of goods sold0.00.0
Gross profit0.00.0
            Gross margin 100.0%
Sales and marketing2.30.2
Research and development19.43.7
General and administrative8.82.5
EBIT-30.6-6.3
            EBIT margin -79037.5%
Pre-tax income-40.5-6.2
Income taxes-0.20.2
            Tax rate0.4% 
Net income-40.3-7.9
            Net margin -98675.0%
 
Diluted EPS($3.11)($0.79)
Shares outstanding (diluted)13.09.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy